Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response
US11730810B2 · kind B2 · utility
0Cited by
5References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 14, 2018 |
| Grant date | Aug 22, 2023 |
| Priority date | — |
| Expiry date | Oct 20, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are imidazopyrimidine compounds, such as compounds of Formula (I), for use in enhancing human immune response and/or as adjuvants in vaccines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.